Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0000950170-25-062060·Orchestra BioMed Holdings, Inc.
Schedule 13D ownership disclosure
Orchestra BioMed Holdings Inc
Common Stock, par value $0.0001 per share · CUSIP: 68572M106
Event date: 2025-04-29
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- RTW Investments, LPReported CIK 0001493215
Shares: 8,306,063 · Class: 21.7%
- RTW Master Fund, Ltd.Reported CIK 0001493219
Shares: 4,394,985 · Class: 11.5%
- RTW Innovation Master Fund, Ltd.Reported CIK 0001776733
Shares: 3,053,082 · Class: 8.0%
- Roderick Wong, M.D.Reported CIK 0001493280
Shares: 8,306,063 · Class: 21.7%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950170-25-062060
- Form type
- SCHEDULE 13D/A
- Filer
- Orchestra BioMed Holdings, Inc.
- CIK
- CIK 1814114
- Filed
- May 01, 2025
- Reporting period
- Apr 29, 2025
- Description
- Schedule 13D beneficial ownership